Drugs Xagena
The European Commission has approved Zejula ( Niraparib ), an oral, once-daily PARP [ poly(ADP-ribose)polymerase ] inhibitor, as first-line monotherapy maintenance treatment for adult patients with ad ...
Some 90% of ovarian cancer are of epithelial cell type: among them, 75% of cases are represented by the high-grade serous ovarian cancer (HG-SOC) and the remaining 10% are non-epithelial ovarian cance ...
